Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
MedPal AILSE:MPAL Debt-to-Equity is 1.45 as of Feb. 2026. The stock has 1 warning sign investors should review. Among 556 Healthcare Providers & Services companies, MedPal AI ranks worse than 82.91% on this metric.
A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.
The historical rank and industry rank for MedPal AI's Debt-to-Equity or its related term are showing as below:
LSE:MPAL'
s Debt-to-Equity Range Over the Past 10 Years
Min: -1.4 Med: -0.75 Max: 1.45
Current: 1.45
During the past 4 years, the highest Debt-to-Equity Ratio of MedPal AI was 1.45. The lowest was -1.40. And the median was -0.75.
LSE:MPAL's Debt-to-Equity is ranked worse than 82.91% of 556
companies
in the Healthcare Providers & Services industry
Industry Median: 0.405
vs LSE:MPAL: 1.45
Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.
MedPal AI Debt-to-Equity Related Terms
MedPal AI Debt-to-Equity Historical Data
* Premium members only.
The historical data trend for MedPal AI's Debt-to-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LSE:MPAL vs VEEV, BTSG, HQY: Debt-to-Equity Comparison
For the Health Information Services subindustry, MedPal AI's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
MedPal AI Debt-to-Equity vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, MedPal AI's Debt-to-Equity distribution charts can be found below:
* The bar in red indicates where MedPal AI's Debt-to-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MedPal AI (LSE:MPAL) has a Debt-to-Equity of 1.45 as of Feb. 2026. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on MedPal AI and its competitors. According to the industry distribution chart, MedPal AI ranks #461 out of 556 companies in the Healthcare Providers & Services industry, placing it in the top 82.9%.
Is MedPal AI's Debt-to-Equity too high?
MedPal AI's current Debt-to-Equity is 1.45. The Healthcare Providers & Services industry median Debt-to-Equity is 0.41. MedPal AI's value of 1.45 is 258% above this industry median. Based on the distribution chart, MedPal AI ranks #461 out of 556 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers.
How does MedPal AI's Debt-to-Equity compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, MedPal AI ranks #461 out of 556 companies for Debt-to-Equity. This places MedPal AI in the lower half of its industry. The industry median Debt-to-Equity is 0.41. MedPal AI's value of 1.45 is 258% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Equity for a Healthcare Providers & Services company?
The median Debt-to-Equity among Healthcare Providers & Services companies is 0.41, based on 556 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-Equity significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. MedPal AI's current Debt-to-Equity of 1.45 is 258% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Equity mean?
A high Debt-to-Equity can signal that a stock is expensive relative to its fundamentals. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on MedPal AI and its competitors. For the Healthcare Providers & Services industry, the median Debt-to-Equity is 0.41 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MedPal AI's current Debt-to-Equity is 1.45. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MedPal AI stock overvalued right now?
MedPal AI (LSE:MPAL) has a current Debt-to-Equity of 1.45. The current Debt-to-Equity is 1.45 and 258% above the Healthcare Providers & Services industry median of 0.41. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Equity calculated?
Debt-to-Equity is calculated from a company's financial statements. For MedPal AI (LSE:MPAL), the current Debt-to-Equity is 1.45 as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
MedPal AI PLC is a UK-based digital health and artificial intelligence company focused on the development and commercialisation of AI-enabled healthcare platforms.. Its platform aggregates data across devices and apps (including Apple Health, Fitbit, Garmin, and Google Fit) to deliver real-time, personalized health insights. The Company has two reportable segments, Software and Corporate.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LSE:MPAL has been successfully added to your 
